Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
To access this article, please choose from the options below
Sponsored by Corthera, Inc. S.T., E.U., and S.W. are employees of Corthera.
PII: S1071-9164(09)00030-X
doi:10.1016/j.cardfail.2009.01.008
© 2009 Elsevier Inc. All rights reserved.
